Toggle light / dark theme

Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive ImpairmentImplications for Anti-Amyloid Therapy

Risk of new indications for anticoagulants and thrombolytics in people with cognitive impairment: implications for anti-amyloid therapy.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.

/* */